NDRG1 and prostate carcinoma: Western-blot analysis of PrECs and the three prostate cancer cell lines was then performed using two NDRG1 primary antibodies targeted to either the C-terminal epitope of NDRG1 (amino acids 384–392) or the N-terminal epitope of NDRG1 (amino acids 19–48).